comparemela.com
Home
Live Updates
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting : comparemela.com
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
Allogeneic iNKTs, agenT-797, administered alone or in combination with anti-PD-1 therapy, shows activity in patients with refractory solid tumor cancers.In a patient with metastatic gastric cancer who... | April 18, 2023
Related Keywords
United States ,
New York ,
Memorial Sloan Kettering Cancer Center ,
American ,
Jennifer Buell ,
Benedito Carneiro ,
Zack Armen ,
Alexa Buffa ,
Yelena Janjigian ,
Lifespan Cancer Institute ,
Clinical Research ,
Gastrointestinal Oncology Service ,
American Association Of Cancer Research ,
American Association ,
Cancer Research ,
Chief Gastrointestinal Oncology ,
Memorial Sloan Kettering Cancer ,
Phasei Clinical Trials ,
Tuesday April ,
Risk Factors ,
Mink Therapeutics ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Allogeneic ,
Administered ,
Alone ,
Dr ,
N ,
Combination ,
Ith ,
Shows ,
Activity ,
Patients ,
Refractory ,
Olid ,
Humor ,
Patient ,
Metastatic ,
Pastric ,
Ancer Inkt Us6036931029 ,
comparemela.com © 2020. All Rights Reserved.